17th Alzheimer’s Australia Biennial National Dementia Conference 2017

Digital Posters by Bill Ketelbey
XanADu: A Phase II trial of Xanamem in mild Alzheimer's disease
XanADu: A Phase II trial of Xanamem in mild Alzheimer's disease
Thursday 19th October 1:40pm to 1:45pm